84 related articles for article (PubMed ID: 26430824)
1. Cytoprotective Effects of a Novel Nrf2 Activator, RS9, in Rhodopsin Pro347Leu Rabbits.
Nakagami Y; Hatano E; Inoue T; Yoshida K; Kondo M; Terasaki H
Curr Eye Res; 2016 Aug; 41(8):1123-1126. PubMed ID: 26430824
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
3. A novel nuclear factor erythroid 2-related factor 2 (Nrf2) activator RS9 attenuates brain injury after ischemia reperfusion in mice.
Yamauchi K; Nakano Y; Imai T; Takagi T; Tsuruma K; Shimazawa M; Iwama T; Hara H
Neuroscience; 2016 Oct; 333():302-10. PubMed ID: 27474227
[TBL] [Abstract][Full Text] [Related]
4. Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.
Nakagami Y; Masuda K; Hatano E; Inoue T; Matsuyama T; Iizuka M; Ono Y; Ohnuki T; Murakami Y; Iwasaki M; Yoshida K; Kasuya Y; Komoriya S
Br J Pharmacol; 2015 Mar; 172(5):1237-49. PubMed ID: 25363737
[TBL] [Abstract][Full Text] [Related]
5. RS9, a novel Nrf2 activator, attenuates light-induced death of cells of photoreceptor cells and Müller glia cells.
Inoue Y; Shimazawa M; Noda Y; Nagano R; Otsuka T; Kuse Y; Nakano Y; Tsuruma K; Nakagami Y; Hara H
J Neurochem; 2017 Jun; 141(5):750-765. PubMed ID: 28345128
[TBL] [Abstract][Full Text] [Related]
6. Functional and morphological study of retinal photoreceptor cell degeneration in transgenic rabbits with a Pro347Leu rhodopsin mutation.
Asakawa K; Ishikawa H; Uga S; Mashimo K; Shimizu K; Kondo M; Terasaki H
Jpn J Ophthalmol; 2015 Sep; 59(5):353-63. PubMed ID: 26245743
[TBL] [Abstract][Full Text] [Related]
7. A triterpenoid Nrf2 activator, RS9, promotes LC3-associated phagocytosis of photoreceptor outer segments in a p62-independent manner.
Saito Y; Yako T; Otsu W; Nakamura S; Inoue Y; Muramatsu A; Nakagami Y; Shimazawa M; Hara H
Free Radic Biol Med; 2020 May; 152():235-247. PubMed ID: 32217192
[TBL] [Abstract][Full Text] [Related]
8. Course of loss of photoreceptor function and progressive Müller cell gliosis in rhodopsin P347L transgenic rabbits.
Ueno S; Kominami T; Okado S; Inooka D; Kondo M; Terasaki H
Exp Eye Res; 2019 Jul; 184():192-200. PubMed ID: 31029790
[TBL] [Abstract][Full Text] [Related]
9. A novel Nrf2 activator from microbial transformation inhibits radiation-induced dermatitis in mice.
Nakagami Y; Masuda K
J Radiat Res; 2016 Sep; 57(5):567-571. PubMed ID: 27242339
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa.
Green ES; Menz MD; LaVail MM; Flannery JG
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1546-53. PubMed ID: 10798675
[TBL] [Abstract][Full Text] [Related]
11. Focal cone ERGs of rhodopsin Pro347Leu transgenic rabbits.
Ueno S; Koyasu T; Kominami T; Sakai T; Kondo M; Yasuda S; Terasaki H
Vision Res; 2013 Oct; 91():118-23. PubMed ID: 23973440
[TBL] [Abstract][Full Text] [Related]
12. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology.
Machida S; Kondo M; Jamison JA; Khan NW; Kononen LT; Sugawara T; Bush RA; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3200-9. PubMed ID: 10967084
[TBL] [Abstract][Full Text] [Related]
13. NFE2L2 activator RS9 protects against corneal epithelial cell damage in dry eye models.
Matsuda Y; Machida M; Nakagami Y; Nakajima T; Azuma M
PLoS One; 2020; 15(4):e0229421. PubMed ID: 32320433
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Protection of Genetically Ablated Rabbit Retinal Degeneration by Sustained Transscleral Unoprostone Delivery.
Nagai N; Koyanagi E; Izumida Y; Liu J; Katsuyama A; Kaji H; Nishizawa M; Osumi N; Kondo M; Terasaki H; Mashima Y; Nakazawa T; Abe T
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6527-6538. PubMed ID: 27918826
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Injection of Proinsulin-Loaded Microspheres Delays Photoreceptor Cell Death and Vision Loss in the rd10 Mouse Model of Retinitis Pigmentosa.
Isiegas C; Marinich-Madzarevich JA; Marchena M; Ruiz JM; Cano MJ; de la Villa P; Hernández-Sánchez C; de la Rosa EJ; de Pablo F
Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3610-8. PubMed ID: 27391551
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of ON-bipolar cell responses of cone electroretinograms in rabbits with the Pro347Leu rhodopsin mutation.
Nishimura T; Machida S; Kondo M; Terasaki H; Yokoyama D; Kurosaka D
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7610-7. PubMed ID: 21873670
[TBL] [Abstract][Full Text] [Related]
17. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa.
Li ZY; Wong F; Chang JH; Possin DE; Hao Y; Petters RM; Milam AH
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):808-19. PubMed ID: 9538889
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic stability of Pro347Leu rhodopsin transgenic pigs as indicated by photoreceptor cell degeneration.
Sommer JR; Wong F; Petters RM
Transgenic Res; 2011 Dec; 20(6):1391-5. PubMed ID: 21340525
[TBL] [Abstract][Full Text] [Related]
19. Photoreceptor and post-photoreceptoral contributions to photopic ERG a-wave in rhodopsin P347L transgenic rabbits.
Hirota R; Kondo M; Ueno S; Sakai T; Koyasu T; Terasaki H
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1467-72. PubMed ID: 22273723
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa.
Tam BM; Moritz OL
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3234-41. PubMed ID: 16877386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
